The Comparative Study of the Frequency of P53 and Ki67 Markers in Ovarian Epithelial Tumors and Their Relationship with Survival in Patients Presenting to Shahid Sadoughi Hospital of Yazd in 2013

The Comparative Study of the Frequency of P53 and Ki67 Markers in Ovarian Epithelial Tumors and Their Relationship with Survival in Patients Presenting to Shahid Sadoughi Hospital of Yazd in 2013–2017

Published:2018-04-24 Issue:2 Volume:16 Page:
ISSN:2363-8397
Container-title:Indian Journal of Gynecologic Oncology
language:en
Short-container-title:Indian J Gynecol Oncolog

Author:

Taghipour Zahir Shokouh,Nahangi Hedeye,Rahmani Koorosh,Aalipour Ezatollah,Baghi Yazdi Mohammad

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

http://link.springer.com/article/10.1007/s40944-018-0202-0/fulltext.html

Reference13 articles.

1. Mahadevappa A, Krishna SM, Vimala MG. Diagnostic and prognostic significance of Ki-67 immunohistochemical expression in surface epithelial ovarian carcinoma. J Clin Diagn Res. 2017;11(2):EC08–12. https://doi.org/10.7860/JCDR/2017/24350.9381 .

2. Sylvia MT, Kumar S, Dasari P. The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables. Indian J Pathol Microbiol. 2012;55(1):33–7. https://doi.org/10.4103/0377-4929.94852 .

3. Kamal CK, Simionescu CE, Mărgăritescu C, Stepan A. P53 and Ki67 immunoexpression in mucinous malignant ovarian tumors. Rom J Morphol Embryol. 2012;53(3 Suppl):799–803.

4. Giurgea LN, Ungureanu C, Mihailovici MS. The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors. Rom J Morphol Embryol. 2012;53(4):967–73.

5. Gursan N, Sipal S, Calik M, Gundogdu C. P53, bcl-2, ki-67 li (labeling index) status in benign, proliferative, and malignant ovarian surface epithelial neoplasms. Eurasian J Med. 2009;41(1):10–4.